Detalhe da pesquisa
1.
Efficacy and safety of idecabtagene vicleucel in patients with relapsed-refractory multiple myeloma not meeting the KarMMa-1 trial eligibility criteria: A real-world multicentre study.
Br J Haematol;
204(4): 1293-1299, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38263627
2.
Abnormal metaphase cytogenetics predicts venous thromboembolism in myeloma: derivation and validation of the PRISM score.
Blood;
140(23): 2443-2450, 2022 12 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35772005
3.
Outcomes of therapeutic plasma exchange for the treatment of patients with multiple myeloma cast nephropathy.
Hematol Oncol;
42(4): e3293, 2024 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38872511
4.
Evaluating ChatGPT as an educational resource for patients with multiple myeloma: A preliminary investigation.
Am J Hematol;
99(6): 1205-1207, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38602288
5.
Current Novel Targeted Therapeutic Strategies in Multiple Myeloma.
Int J Mol Sci;
25(11)2024 Jun 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38892379
6.
External validation of the SAVED score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulatory drugs.
Br J Haematol;
201(2): 280-284, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36604838
7.
Intravenous immunoglobulin prophylaxis is associated with decreased rate of infection-related hospitalizations in multiple myeloma patients.
Hematol Oncol;
41(4): 718-724, 2023 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37231908
8.
Waldenström macroglobulinemia: a review of pathogenesis, current treatment, and future prospects.
Ann Hematol;
2023 Jul 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37414960
9.
Clinical Research in Chronic Lymphocytic Leukemia in Pakistan; A Systematic Review.
Medicina (Kaunas);
59(8)2023 Aug 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37629773
10.
Impact of autologous transplantation on survival in patients with newly diagnosed multiple myeloma who have high-risk cytogenetics: A meta-analysis of randomized controlled trials.
Cancer;
128(12): 2288-2297, 2022 06 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35377484
11.
Efficacy and safety of regimens used for the treatment of multicentric Castleman disease: A systematic review.
Eur J Haematol;
109(4): 309-320, 2022 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35770616
12.
Toxicity analysis of busulfan pharmacokinetic therapeutic dose monitoring.
J Oncol Pharm Pract;
: 10781552221104422, 2022 Jun 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35673764
13.
Validation of the IMPEDE VTE score for prediction of venous thromboembolism in multiple myeloma: a retrospective cohort study.
Br J Haematol;
193(6): 1213-1219, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33997961
14.
Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019.
BMC Cancer;
21(1): 730, 2021 Jun 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34172037
15.
Dawn of a new era of antibody-drug conjugates and bispecific T-cell engagers for treatment of multiple myeloma: a systematic review of literature.
Ann Hematol;
100(9): 2155-2172, 2021 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34318356
16.
Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblast Leukemia: A Systematic Review.
Biol Blood Marrow Transplant;
26(3): e55-e64, 2020 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31557532
17.
Revisiting Role of Vaccinations in Donors, Transplant Recipients, Immunocompromised Hosts, Travelers, and Household Contacts of Stem Cell Transplant Recipients.
Biol Blood Marrow Transplant;
26(2): e38-e50, 2020 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31682981
18.
Single-Agent Cyclosporine for Graft-versus-Host Disease Prophylaxis in Patients with Acquired Aplastic Anemia Receiving Fludarabine-Based Conditioning.
Biol Blood Marrow Transplant;
26(12): 2245-2251, 2020 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32717437
19.
Venous thromboembolism risk with contemporary lenalidomide-based regimens despite thromboprophylaxis in multiple myeloma: A systematic review and meta-analysis.
Cancer;
126(8): 1640-1650, 2020 04 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31913498
20.
Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma.
Br J Haematol;
189(6): 1074-1082, 2020 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32108328